As of 2025-07-14, the Relative Valuation of Haemonetics Corp (HAE) is 97.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 75.52 USD, the upside of Haemonetics Corp based on Relative Valuation is 29.6%.
The range of the Relative Valuation is 75.61 - 122.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 35.2x | 28.6x |
| Forward P/E multiples | 19.4x - 29.7x | 24.5x |
| Fair Price | 75.61 - 122.86 | 97.84 |
| Upside | 0.1% - 62.7% | 29.6% |
| Date | P/E |
| 2025-07-11 | 21.64 |
| 2025-07-10 | 22.40 |
| 2025-07-09 | 22.21 |
| 2025-07-08 | 21.77 |
| 2025-07-07 | 21.52 |
| 2025-07-03 | 22.02 |
| 2025-07-02 | 21.84 |
| 2025-07-01 | 21.87 |
| 2025-06-30 | 21.38 |
| 2025-06-27 | 21.14 |
| 2025-06-26 | 21.42 |
| 2025-06-25 | 21.03 |
| 2025-06-24 | 20.93 |
| 2025-06-23 | 20.65 |
| 2025-06-20 | 20.36 |
| 2025-06-18 | 20.07 |
| 2025-06-17 | 19.77 |
| 2025-06-16 | 20.04 |
| 2025-06-13 | 20.08 |
| 2025-06-12 | 20.44 |
| 2025-06-11 | 20.49 |
| 2025-06-10 | 20.67 |
| 2025-06-09 | 20.53 |
| 2025-06-06 | 20.19 |
| 2025-06-05 | 20.17 |
| 2025-06-04 | 19.96 |
| 2025-06-03 | 19.96 |
| 2025-06-02 | 19.71 |
| 2025-05-30 | 19.40 |
| 2025-05-29 | 19.44 |
| 2025-05-28 | 19.37 |
| 2025-05-27 | 19.48 |
| 2025-05-23 | 18.93 |
| 2025-05-22 | 18.95 |
| 2025-05-21 | 19.17 |
| 2025-05-20 | 19.74 |
| 2025-05-19 | 19.87 |
| 2025-05-16 | 20.14 |
| 2025-05-15 | 19.88 |
| 2025-05-14 | 19.67 |
| 2025-05-13 | 19.81 |
| 2025-05-12 | 20.12 |
| 2025-05-09 | 19.54 |
| 2025-05-08 | 19.48 |
| 2025-05-07 | 18.41 |
| 2025-05-06 | 18.22 |
| 2025-05-05 | 17.90 |
| 2025-05-02 | 18.29 |
| 2025-05-01 | 18.05 |
| 2025-04-30 | 18.06 |